Clinical Study on Options of Medication Regimen in Treatment of Refractory Obsessive-Compulsive Disorder Patients
Condition: Obsessive-Compulsive Disorder Interventions: Drug: Sertraline 200 milligram(mg); Drug: Sertraline 300 milligram(mg); Drug: Fluvoxamine; Drug: Venlafaxine; Drug: Augment with Memantine; Drug: Augment with Aripiprazole Sponsors: Shanghai Mental Health Center; The first specialized hospital of harbin; Guizhou Provincial People's Hospital; First Affiliated Hospital of Jinan University; West China Hospital; Suzhou Psychiatric Hospital; Nanjing Medical University; Wuhan Mental He alth Centre; Hangzhou Seventh People's Hospital; The First Affiliated Hospital of Kunming Medical College; General Hospital of Ningxia Medical University; The First Affiliated Hospital of Nanchang University; Henan Mental Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abilify | Effexor | Hospitals | Men | Namenda | Obsessive Compulsive Disorder | Psychiatry | Research | Study